Jacob Thyrsted
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus families.
Journal: Redox biology
Published: March 04, 2026
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment.
Journal: Nature communications
Published: December 21, 2022
TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection.
Journal: The EMBO journal
Published: September 01, 2021
Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium.
Journal: iScience
Published: June 30, 2021
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
Journal: Nature communications
Published: October 22, 2020
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro.
Journal: Antiviral research
Published: July 22, 2020
SARS-CoV-2 evades immune detection in alveolar macrophages.
Journal: EMBO reports
Published: July 07, 2020
Virus-induced metabolic reprogramming and innate sensing hereof by the infected host.
Journal: Current opinion in biotechnology
Published: June 29, 2020
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
Journal: Nature communications
Published: May 14, 2020
Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming.
Journal: Nature communications
Published: March 14, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026